Boston Biomedical has appointed Edgar Braendle to serve as executive vice president, head of research and development, and chief medical officer. Before joining the Boston-based cancer drug developer, Braendle was president and CEO of ARUP Laboratories in Salt Lake City. He also previously worked at Novartis (NYSE: [[ticker:NVS]]), where he was global head of the company’s companion diagnostics division.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
